Microfluidic Device for High-Throughput Single Cell Stimulation and Visualization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current microfluidic devices are limited in their ability to perform high-throughput screening of living cells using minimal reagents, while allowing for the tracking of individual cells over time, due to limitations in reagent volume, throughput, and precise control of fluid flow.
Innovation Solution
The development of microfluidic devices with a series of parallel fluid channels that are individually addressable through a multiplexer system, composed of biocompatible materials like PDMS, allowing for precise control of fluid flow and reagent use, enabling in situ cell stimulation, staining, and visualization.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If cells are stained using immunofluorescence on glass slides, then visualization of cells is achieved, but large volumes of reagents are required
Solution Approach 1:
The device segments the fluid handling system into multiple parallel channels, each capable of independent cell stimulation and staining. This segmentation allows reagents to be delivered precisely to individual channels containing specific cells, thereby reducing the overall reagent volume required compared to traditional slide-based methods where reagents must cover entire slide surfaces.
2Adaptability or versatility
If multiple cell assays are performed in parallel under different conditions, then comprehensive cell screening is achieved, but labor intensity increases and throughput decreases
Solution Approach 1:
The microfluidic device is designed with multi-functionality, where a single device can perform multiple different cell assays in parallel under various conditions. The device includes multiple channels that can be independently configured for different stimulation conditions, time courses, or antibody treatments, allowing comprehensive cell screening without increasing labor intensity or reducing throughput.
Solution Approach 2:
The device incorporates automated fluid handling and valve control systems that enable self-service operation. The microfluidic system automatically delivers reagents, controls flow rates, and manages multiple assay conditions without requiring manual intervention for each channel, thereby maintaining high throughput while accommodating diverse assay conditions.
3Measurement precision
If cells are captured and held in place using a drain channel, then single cell positioning is achieved, but cell viability and stress pathway activation become uncertain
Solution Approach 1:
The device applies local quality by providing different environmental conditions to different regions of the device. Cells in the capture channel receive targeted reagent delivery and controlled fluid flow conditions specific to their location, while maintaining overall system stability. This localized control allows precise single cell positioning while preserving cell viability through optimized local microenvironment conditions.
4Duration of action of stationary object
If elastomeric devices with individual microwells are used for cell culture, then single cell tracking over time is enabled, but all cells are exposed to the same stimuli reducing screening capability
Solution Approach 1:
The device segments the fluid delivery system into multiple independent channels, each capable of receiving different stimuli while maintaining long-term cell culture. This segmentation allows cells to be tracked over time in individual channels while simultaneously exposing different channels to varied stimuli, thereby combining the advantages of longitudinal tracking with high-throughput screening capability.
Data Source
AI summary
Cell stimulation, staining, and visualization are common techniques in both clinical and research settings. The invention is directed to microfluidic devices for in situ cell stimulation, staining, and/or visualization, and related methods for applying one or more stimuli to the cells, and fixing and staining of cells in situ. The device allows for high-throughput screening of living cells using a minimal quantity of reagents where the fate of individual cells can be followed over time.

